

K.R.R. Drugs & Intermediates Profile
Key Indicators
- Authorised Capital ₹ 2.50 Cr
- Paid Up Capital ₹ 2.50 M
- Company Age 23 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 15.43 Cr
- Revenue Growth %
- Profit Growth -7.32%
- Ebitda -15.72%
- Net Worth -23.43%
- Total Assets -5.99%
About K.R.R. Drugs & Intermediates
K.R.R. Drugs & Intermediates Private Limited (KDIPL) is a Private Limited Indian Non-Government Company incorporated in India on 30 January 2002 and has a history of 23 years and one month. Its registered office is in Ameerpet, Hyderabad., Andhra Pradesh, India.
The Corporate was formerly known as Medeva Laboratories Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 Cr and a paid-up capital of Rs 2.50 M.
The company has closed loans amounting to ₹15.43 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Sundeep Kattamuri and Subbarao Kattamuri serve as directors at the Company.
Company Details
- Location
Ameerpet, Hyderabad., Andhra Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24239AP2002PTC038417
- Company No.
038417
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Jan 2002
- Date of AGM
31 Jul 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
What products or services does K.R.R. Drugs & Intermediates Private Limited offer?
K.R.R. Drugs & Intermediates Private Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, Anti Infective API.
Who are the key members and board of directors at K.R.R. Drugs & Intermediates?
Board Members (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sundeep Kattamuri ![]() | Director | 08-Jul-2015 | Current |
Subbarao Kattamuri ![]() | Director | 08-Jul-2015 | Current |
Financial Performance of K.R.R. Drugs & Intermediates.
K.R.R. Drugs & Intermediates Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a slight decrease in profitability, with a 7.32% decrease in profit. The company's net worth observed a substantial decline by a decrease of 23.43%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of K.R.R. Drugs & Intermediates?
In 2023, K.R.R. Drugs & Intermediates had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Related Corporates (Common Directorship)
- Evertogen Life Sciences Limited
Subbarao Kattamuri is a mutual person
- Glochem Api Private Limited
Subbarao Kattamuri is a mutual person
- Xperte Learnware Llp
Sundeep Kattamuri is a mutual person
- Lightning Truck Logistics Llp
Sundeep Kattamuri is a mutual person
- Talpona Beach Resort Llp
Sundeep Kattamuri is a mutual person
- Cloud Xperte Professional Services Llp
Sundeep Kattamuri is a mutual person
Charges (Loans)
₹0
₹15.43 Cr
Charges Breakdown by Lending Institutions
- Syndicate Bank : 12.60 Cr
- Central Bank Of India : 2.83 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
04 Oct 2014 | Syndicate Bank | ₹7.40 Cr | Satisfied |
01 Aug 2005 | Syndicate Bank | ₹2.75 Cr | Satisfied |
01 Aug 2005 | Syndicate Bank | ₹1.14 Cr | Satisfied |
08 Jun 2005 | Syndicate Bank | ₹1.31 Cr | Satisfied |
22 Mar 2004 | Central Bank Of India | ₹2.83 Cr | Satisfied |
How Many Employees Work at K.R.R. Drugs & Intermediates?
K.R.R. Drugs & Intermediates has a workforce of 6 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of K.R.R. Drugs & Intermediates, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped K.R.R. Drugs & Intermediates's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on K.R.R. Drugs & Intermediates
Recent activity within the organization
- Annual General Meeting
K.R.R. Drugs & Intermediates Private Limited last Annual general meeting of members was held on 31 Jul 2023 as per latest MCA records.
- Balance Sheet
K.R.R. Drugs & Intermediates Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Vijayawada.
- Director Appointment
Sundeep Kattamuri was appointed as a Director was appointed as a Director on 08 Jul 2015 & has been associated with this company since 9 years 8 months .
- Director Appointment
Subbarao Kattamuri was appointed as a Director was appointed as a Director on 08 Jul 2015 & has been associated with this company since 9 years 8 months .
- Charges
A charge registered on 04 Oct 2014 via Charge ID 10532574 with Syndicate Bank was fully satisfied on 02 Jun 2015.
- Charges
A charge registered on 01 Aug 2005 via Charge ID 90133288 with Syndicate Bank was fully satisfied on 08 Jan 2015.
Frequently asked questions
What is the Incorporation or founding date of K.R.R. Drugs & Intermediates Private Limited?
K.R.R. Drugs & Intermediates Private Limited was incorporated on 30 Jan 2002.
What is authorized share capital and paid-up capital of K.R.R. Drugs & Intermediates Private Limited?
The authorized share capital of K.R.R. Drugs & Intermediates Private Limited is ₹ 2.50 Cr and paid-up capital is ₹ 2.50 M.
Who are the current board members & directors of K.R.R. Drugs & Intermediates Private Limited?
Currently 2 directors are associated with K.R.R. Drugs & Intermediates Private Limited.
- Sundeep Kattamuri
- Subbarao Kattamuri
What is the registered address of K.R.R. Drugs & Intermediates Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of K.R.R. Drugs & Intermediates Private Limited is Flat No.406 Aditya Trade Centre, Ameerpet Hyderabad., Andhra Pradesh, India, 500038.
What is the corporate identification number (CIN) and company number of K.R.R. Drugs & Intermediates Private Limited?
The corporate identification number (CIN) of K.R.R. Drugs & Intermediates Private Limited is U24239AP2002PTC038417 and the company number is 038417 as per Ministry of Corporate Affairs (MCA).
What is the official website of K.R.R. Drugs & Intermediates Private Limited?
The Official website of K.R.R. Drugs & Intermediates Private Limited is https://www.krrdrugs.com
How many employees does K.R.R. Drugs & Intermediates Private Limited currently have?
As Per 2023 financial reports, 6 employees are currently employed by K.R.R. Drugs & Intermediates Private Limited.
What change has been observed in the net worth of K.R.R. Drugs & Intermediates Private Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of K.R.R. Drugs & Intermediates Private Limited has experienced an downturn of -23.43%.
When was the last Balance Sheet of K.R.R. Drugs & Intermediates Private Limited filed with the ROC?
The most recent Balance Sheet for K.R.R. Drugs & Intermediates Private Limited was filed with the ROC on 31 Mar 2023.
People also Viewed
- Kalyan NagururuDirector
- Chandan KumarDirector
VR
Venkata RajuAdditional DirectorVV
Venugopal VanteruManaging DirectorCR
Chittabathuni ReddyDirectorVD
Venkateswara DronadulaDirectorVV
Vamsi VanteruWhole-Time DirectorMV
Murali VadlamudiAdditional Director
Similar Companies Based on API Manufacturers
- Mylan Laboratories Limited Hyderabad, Telangana, India
- Sun Pharmaceutical Industries Limited Vadodara, Gujarat, India
- Msn Laboratories Private Limited Rangareddy, Telangana, India
- Lupin Limited Mumbai, Maharashtra, India
- Ipca Laboratories Limited Mumbai, Maharashtra, India
- Divi's Laboratories Limited Rangareddy, Telangana, India
- Hetero Labs Limited Rangareddy, Telangana, India
- Glenmark Pharmaceuticals Limited Mumbai, Maharashtra, India